Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group

Neurology. 2000 Dec 12;55(11):1735-7. doi: 10.1212/wnl.55.11.1735.

Abstract

Analysis of the gene GCH1 in 58 patients with dystonia and a positive response to L-dopa revealed mutations in 30 individuals from 22 families. Thirteen of the mutations observed were familial, three occurred de novo, and inheritance could not be determined in six cases. There was no mutation in the promoter region of GCH1 in any patient. The doses of L-dopa given to members of the two groups were not significantly different.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Child
  • Dihydroxyphenylalanine / therapeutic use*
  • Dystonia / drug therapy*
  • Dystonia / genetics*
  • Female
  • GTP Cyclohydrolase / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics

Substances

  • Dihydroxyphenylalanine
  • GTP Cyclohydrolase